🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to be at the ICIS 🦋 @cytokinesociety.bsky.social Cytokines 2024 conference in Seoul and looking forward to presenting my work on STAT rebalancing on Tuesday

It was an honor to present some key findings of my thesis work at ICIS 🦋 @cytokinesociety.bsky.social Cytokines 2024 today in Seoul! Made some great connections and am excited for new opportunities to collaborate

New research from StanfordMCP describes the structural mechanism that enables #adenoviruses to escape immunity by targeting #CD45 on T cells. Read more in Science #Immunology: bit.ly/3UohnMR

Amazing work from my lab-mates Marta Borowska and Liu "Daisy" Liu!

Last month, I successfully defended my PhD in Immunology at Stanford University! I am beyond grateful to my family, friends, colleagues, Stanford Immunology, and advisor, Chris Garcia, for their support in reaching this milestone.

⭐️NEW PAPER OUT in nature⭐️ 🫀What is the relationship between the immune responses in the heart, blood, and tumor in patients with inflammation in the heart resulting from cancer immunotherapy (irMyocarditis)? This 🧵 breaks down the key findings 1/n nature.com/articles/s4158…

Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research The Parker Institute for Cancer Immunotherapy (Parker Institute for Cancer Immunotherapy) announces its inaugural RISE Scholars, funding seven researchers with $75,000 each to tackle critical challenges in immunotherapy.

🚨New paper alert! 🚨 Our latest work in Immunity shows that Ark313, an evolved AAV variant enables in vivo genetic engineering of murine T cells! 🧵👇 sciencedirect.com/science/articl…

The Trump administration's efforts to slash research funding have US graduate students, postdocs and other early-career scientists fearing for their careers. Some are considering changing jobs or leaving the country. Others say them might abandon research altogether.

Redirecting immune signaling with cytokine adaptors nature.com/articles/s4146… Nature Communications Gita Abhiraman

Congratulations Gita Abhiraman, so much fun working together on this exciting project 🎉

Targeted degradation of α-Synuclein using an evolved botulinum toxin protease | PNAS pnas.org/doi/10.1073/pn…

Age-dependent cytokine surge in blood precedes cancer diagnosis pnas.org/doi/10.1073/pn…

Off-the-shelf CAR-NKT cells for cancer immunotherapy are advanced toward clinical translation go.nature.com/4akbFkj rdcu.be/efeUJ

To reroute a cytokine’s signaling, Abhiraman et al. generated soluble adaptors comprising units that bind to two sites on a cytokine linked to units that bind to and compel dimerization/activation of a different cytokine’s receptor. bit.ly/4l0nd2G  Gita Abhiraman

Excited to share my graduate work from the E. John Wherry lab on the molecular mechanisms locking in the differentiation fate of exhausted CD8 T cells (Tex), published earlier this month in @SciImmuno. Main findings below! science.org/doi/10.1126/sc…

Basic science is the greatest investment this country can make

Without its international students, Harvard is not Harvard. hrvd.me/IntStudents25t

America cannot long remain free, nor first among nations, if it becomes the kind of place where universities are dismantled because they don't align politically with the current head of the government.